Patient monitoring technology offers enormous benefits for the patient. But reimbursement is insufficiently regulated all over Europe. Therefore, telemedicine generates a loss for the physicians although it can very well cut costs for all parties involved and improve the quality of care.
Drug access by older citizens varies widely across 25 EU member countries, according to a new study by IMS Health. Per capita usage of drugs to treat Alzheimer's disease in the five EU countries where utilization was highest was 20 times greater than in the five lowest-use countries.
Intima media thickness (IMT) is a valuable research tool that can be used as surrogate end points in clinical trails, says Professor Stefan Agewall.
Cardiologist Dr Malissa Wood, of the Massachusetts General Hospital, Boston, USA, has reported that a study of Olympic athletes, using GE Healthcare's Vivid I cardiac compact ultrasound technology, has allowed the medical research team in Beijing to identify healthy patterns of heart enlargement that can differentiate it from hypertrophic cardiomyopathy.
An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level. Molecular imaging allows for unique insights into specific disease mechanisms and holds great promise to change the practice of cardiovascular medicine by facilitating early disease detection,…
Syncope (fainting) is a leading cause of hospital emergency visits. In almost 10% of patients, syncope has a cardiac cause; in 50%, a non-cardiac cause, and in 40% the cause of syncope is unknown. Syncope is difficult to diagnose as syncopal episodes are often too infrequent and unpredictable for detection with conventional monitoring techniques.
US- researchers found that inpatients experience an average of nearly one and a half potentially harmful errors in their medication record during a hospital stay. They started the search for the causes: admission and discharging are the most dangerous situations.
It runs and runs and runs The Olympus AU640 clinical chemistry analyser is the most reliable analyser considering a period of 12 months. This is the result published in the NHS Purchasing and Supply Agency Analyser Monitoring Programme Annual Report 2006-2007.
Hospital admission might probably determine the severity of heart failure. By analysing data from 260 hospitals across the United States researchers created a model to reduce in-hospital mortality and more quickly identify triage methods and treatment decisions.
Treadmill exercise testing is a common tool to detect of cardiovascular diseases. But clear images of the working heart are hard to obtain. Now researchers designed MRI equipment to provide high-resolution images of the heart at critical stages.
An international panel of physicians has updated the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection after evaluating recent data, according to an article in JAMA, a theme issue on HIV/AIDS.
Technologically advanced, cost-effective cardiovascular monitoring systems are increasingly in demand in Europe. New analysis from Frost & Sullivan point out that the market will grow from $350.0 million in 2007 and to $491.3 million in 2014.
The Cardiomobile developed by the Institute of Health and Biomedical Innovation at Queensland University, Australia, contains a Mini ECG and a GPS system linked to a mobile phone via Bluetooth. That way heart patients can do rehabilitation exercises any place and any time they want to.
Limited public and political awareness of colorectal cancer (CRC), few formal screenings programms, delayed access to treatment - the first cross-country report on the management and funding of colorectal cancer (CRC) reveals an urgent need for action to improve the survival of patients in Europe and Australia.
Process optimisation concerns all primary and secondary processes in a hospital. Case management is a tool that supports the implementation of comprehensive optimisation efforts.
Siemens Healthcare Diagnostics will showcase the combined strengths of Diagnostics Products Corporation (DPC), Bayer HealthCare Diagnostics and Dade Behring.
Report: Mark Nicholls
Pulsion Medical Systems and Philips Healthcare are two strong brands. Pulsion, one of the leading specialists for intelligent medical diagnosis and therapy management systems, now announced the extension of the alliance with Philips. Among other things the agreement will contain the integration of further Pulsion-technologies into the Philips patient monitoring systems.
On 1st May, Medilog became part of the SCHILLER group. Medilog will be SCHILLER's high-end Holter system. Medilog's additional products are an ideal complement to SCHILLER's present product range. The SCHILLER group very much looks forward to the coming co-operation.
As the opening of the Beijing 2008 Olympic Games nears, the US Olympic Committee (USOC) and the General Electric Company (a Worldwide Partner of the Olympic Games) are running two research programmes aimed at demonstrating that health monitoring and early intervention leads to injury prevention and enhanced health and sports performances for athletes.
Before discussing a possible connection between gadolinium and nephrogenic systemic fibrosis (NSF), Dr Herborn offered a brief background:
Encouraged by the success of the Dual-Source CT system Somatom Definition with two X-ray tubes that simultaneously generate different energies, Siemens Healthcare has already developed six specific dual energy applications. At the ECR 2008, the company presents four new applications that simplify the diagnosis of diseases of the heart, brain, lungs and extremity joints.
Andrea Martini and Joerg Larsen, of the Institute for Roentgendiagnostics, Braunschweig Teaching Hospitals, Germany, discuss nanotechnology, hybrid imaging and the quest for a personalised medicine.
Amyloidb (Ab) plaque formation is a hallmark of Alzheimers disease (AD) and precedes the onset of dementia. Australian researchers reported the first data on the validity in humans of a new PET tracer binding to Ab. Their data suggest that 18F-BAY94-9172 of Bayer Schering Pharma AG can reliably detect Ab deposition and thereby aid early diagnosis, differential diagnosis, and therapeutic…
Molecular imaging aims at the in vivo quantitative visualisation of molecules and molecular events that occur at cellular level. The potential towards clinical translation is huge, because the same modalities used in medical imaging are used in molecular imaging investigations.